Katherine E. Wilson

Katherine E. Wilson

Auto-generated profile, based on publicly available information

Katherine E. Wilson

Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
MMMelissa A Mercer
Melissa A Mercer
HMHarold McKenzie
Harold McKenzie
JDJennifer Davis
Jennifer Davis
KWK. E. Wilson
K. E. Wilson
DHD. R. Hodgson
D. R. Hodgson
BMB. J. McIntosh
B. J. McIntosh

1 December 2009 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
KWKatherine E. Wilson
Katherine E. Wilson
JWJeff R. Wilcke
Jeff R. Wilcke
MCMark V. Crisman
Mark V. Crisman
DWDaniel L. Ward
Daniel L. Ward
HMHarold McKenzie
Harold McKenzie
WSW. Kent Scarratt
W. Kent Scarratt
Objective—To determine whether a limited sampling time method based on serum iohexol clearance (Cliohexol) would yield estimates of glomerular filtration rate (GFR) in clinically normal horses similar to those for plasma creatinine clearance (Clcreatinine). Animals—10 clinically normal adult horses. Procedures—A bolus of iohexol (150 mg/kg) was administered IV, and serum samples were obtained 5, 20, 40, 60, 120, 240, and 360 minutes after injection. Urinary clearance of exogenous creatinine was measured during three 20-minute periods. The GFR determined by use of serum Cliohexol and plasma Clcreatinine was compared with limits of agreement plots. Results—Values obtained for plasma Clcreatinine ranged from 1.68 to 2.69 mL/min/kg (mean, 2.11 mL/min/kg). Mean serum Cliohexol was 2.38 mL/min/kg (range, 1.95 to 3.33 mL/min/kg). Limits of agreement plots indicated good agreement between the methods. Conclusions and Clinical Relevance—Use of serum Cliohexol yielded estimates of GFR in clinically normal adult horses similar to those for plasma Clcreatinine. This study was the first step in the evaluation of the use of serum Cliohexol for estimating GFR in adult horses.

29 April 2017 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
KWK. E. Wilson
K. E. Wilson
JDJ. L. Davis
J. L. Davis
MCM. V. Crisman
M. V. Crisman
VKV. Kvaternick
V. Kvaternick
CZC. Zarabadipour
C. Zarabadipour
DHD. R. Hodgson
D. R. Hodgson

26 October 2022 in Veterinary Surgery
Verified
Journal Article
Closed access
KWKatherine E. Wilson
Katherine E. Wilson
SBSophie H. Bogers
Sophie H. Bogers
RCR. McAlister Council‐Troche
R. McAlister Council‐Troche
JDJennifer L. Davis
Jennifer L. Davis

1 December 2017 in Journal of Equine Veterinary Science
Verified
Journal Article
Open access
NPNicholas J. Parkinson
Nicholas J. Parkinson
KWKatherine E. Wilson
Katherine E. Wilson
GSGeoffrey K. Saunders
Geoffrey K. Saunders
VBVirginia A. Buechner-Maxwell
Virginia A. Buechner-Maxwell
WSW. Kent Scarratt
W. Kent Scarratt
RFRebecca A. Funk
Rebecca A. Funk

1 February 2026 in American Journal of Veterinary Research
Verified
Journal Article
Open access
ELEmilee K. Lacey
Emilee K. Lacey
KWKatherine E. Wilson
Katherine E. Wilson
JDJennifer Davis
Jennifer Davis
Objective: To evaluate the pharmacokinetics of mirtazapine (MRZ) after single-dose oral administration in healthy adult alpacas and compare concentrations at 2 venous sampling sites. Methods: This study was conducted during the weeks of January 29, 2024, and February 15, 2024. A single dose of 2 mg/kg MRZ was administered orally via syringe to 7 healthy adult alpacas. Blood was collected from jugular vein (JV; n = 7) and cephalic vein (CV; 5) catheters immediately prior to and at predetermined times for 24 hours after administration. Plasma MRZ concentrations were determined by UPLC-MS-MS. Pharmacokinetic parameters were determined for each sampling site, and statistical analysis was performed by paired t tests. Results: Mean maximum plasma concentrations (C max ) from JV samples (183 ± 95.2 ng/mL) occurred at time 0.0281 ± 0.029 hours and were significantly higher than CV samples’ C max (4.84 ± 2.37 ng/mL), which occurred at time 0.464 ± 0.093 hours. Comparison of dose-corrected C max and area under the concentration-time curve from time zero extrapolated to infinity with those previously reported show the C max from JV samples in alpacas is similar to cats (166 ng/mL), but the C max from the CV samples failed to reach that reported in dogs (140 ng/mL) and people (123 ng/mL). Conclusions: Plasma concentrations of MRZ were significantly different between sampling sites, resulting in different interpretations for potential use in alpacas. Clinical Relevance: Additional information is needed before using oral MRZ in alpacas, including studies of different doses, formulations, or routes of administration.